Featured Articles:

Episode 53 — How to Test and Evaluate Your Compliance Program

An effective compliance program requires that companies review and improve their compliance programs. A company should regularly review and test its controls, and address potential weaknesses in its compliance program. The Justice Department and the SEC have encouraged companies to conduct regular tests and reviews to create a sustainable compliance program. Companies should design and implement a proactive evaluation program to ensure that their compliance...

CFIUS Reform: An Expanded Role (Part II of II)

Congress enacted the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA), which was intended to modernize and strengthen the CFIUS process.  FIRRMA was incorporated into the National Defense Authorization Act which as passed and signed into law. FIRRMA expands CFIUS jurisdiction to include four new types of transactions, expands the definition of “critical technology,” requires CFIUS to respond to written notices, extends the time...

CFIUS Review: An Increasing Risk (Part I of II)

Washington, D.C. is more than just the nation’s capital.  Companies have to pay attention and develop contacts and relationships in Washington, D.C. given the importance of federal agencies, Congress and of course, the White House.  I often inform clients that Washington, D.C. provides a second round of due process for disputes that may occur in domestic or foreign markets. One of the more important institutions...

DOJ Expands FCPA Corporate Enforcement Policy

The Justice Department’s FCPA Corporate Enforcement Policy was announced in November 2017 with much fanfare – it was the culmination of a step-by-step process beginning with the FCPA Pilot Program.  The FCPA Corporate Enforcement Policy enshrined the potential benefit of a presumption of a declination if a corporation: (1) voluntarily disclosed the misconduct; (2) implemented timely and appropriate remediation; and (3) fully cooperated with the...

Episode 52 — The False Claims Act and Healthcare Fraud

The federal government continues to push aggressive False Claims Act enforcement cases against healthcare companies, including hospitals, skilled nursing facilities, hospices and other healthcare providers.  The Justice Department has employed the False Claims Act to target companies in the opioid industry as a response to the opioid crisis in our country. Healthcare companies have to implement effective ethics and compliance controls to protect against fraud...

New Episode Everything Compliance: The Five-Year Retrospective Edition

Tom Fox, Matt Kelly, Jonathan Armstrong, Jay Rosen and myself recently recorded a new episode of Everything Compliance — Five-Year Retrospective Edition.   You can listen to it here. Everything Compliance is the only roundtable podcast in compliance, with four of the top compliance practitioners around. This week the gang returns to its four focused topics on its Five-Year Retrospective Edition. Matt Kelly considers how did...

Federal Enforcement and the Opioid Epidemic (Part IV of IV)

The scope of our country’s opioid epidemic is devastating.  From 1999 to 2017, more than 700,000 people have died from a drug overdose.  Two-thirds of these deaths involved an opioid.  On average, 195 Americans dies every day from an opioid overdose.  These numbers are tragic and mind-boggling. In response, federal enforcement efforts have primarily focused on criminal prosecutions, but there have also been significant civil...

Webinar: FCPA Risks and Mergers and Acquisitions

Webinar: FCPA Risks and Mergers and Acquisitions September 5, 2018, 12 Noon EST Sign Up HERE Companies confront significant anti-corruption risks when acquiring other businesses. Successor companies have to conduct pre-closing due diligence and manage anti-corruption risks in the integration process. The Justice Department and the SEC have aggressively enforced the FCPA and are now encouraging companies to voluntarily disclose FCPA misconduct and cooperate. Join...

Rolling Along with False Claims Act Enforcement Actions (Part III of IV)

Despite the controversial impact of the Supreme Court’s Escobar decision, the Justice Department’s False Claims Act prosecutions and settlements are continuing at a consistent rate – heading towards another multi-billion dollar year of FCA recoveries. Some examples of these prosecutions and settlements will demonstrate my overall point – FCA risks are significant and healthcare providers, especially hospitals, have to devote time and attention to oversight...

Hospital Official and Three Dentists Convicted for Kickback and Bribery in RICO Criminal Case (Part II of IV)

The Justice Department has continued to pursue healthcare fraud and bribery criminal prosecutions.  Healthcare fraud remains a high priority for criminal enforcement. With the pervasive problem of fraud and bribery, the healthcare industry continues to suffer from corrupt officials and physicians.  Government regulation of the healthcare industry provides many opportunities and incentives for industry participants to cheat the system. In a recent case, the Justice...